[an error occurred while processing the directive]
RSS
Логотип
Баннер в шапке 1
Баннер в шапке 2

Institute of reactor materials

Company


Owners:
Rosatom

Owners

JSC Institute of Reactor Materials (IRM) — the enterprise of Rosatom located in Sverdlovsk region which researches materials for  nuclear power  and also produces radioactive isotopes. At the enterprise the research water-to-water nuclear reactor of the basin IVV-2M type with a rated power of 15 MW is operated.

2017: Expansion of production of medicines for nuclear medicine

At the end of August, 2017 the expert advice of Fund of technology development of Sverdlovsk region approved to "Institute of reactor materials" a loan in the amount of 100 million rubles for development of the project in the organization of high technology production of radiopharmaceuticals and radiation sources for nuclear medicine and the industry.

It is supposed that the main part of funds (about 70%) for  this project will be allocated by Fund of development of the industry. The solution of Fund will give start to implementation of all project.

In the JSC Institute of Reactor Materials enterprise

By means of the raised funds it is going to market technology more difficult connections assuming high value added. The speech first of all goes about  trichloride of lutetium-177 which is used for  treatment of neuroendocrine tumors. Thanks to "address" delivery of this radioisotope to  cancer cells destruction  not only primary malignant tumor,  but also metastases is possible that allows to expect  success even at  late stages of a disease.

Production will be focused on export — foreign customers will become the main consumers. An ultimate goal of development of production is increase in availability of nuclear medicine to domestic consumers.

By the end of August, 2017 trial supply of trichloride of lutetium is already performed to pharmproizvoditel and private clinics first of all for the analysis of product quality.[1]

Notes